Skip to main content

Cyramza Prices, Coupons and Patient Assistance Programs

Cyramza (ramucirumab) is a member of the VEGF/VEGFR inhibitors drug class and is commonly used for Colorectal Cancer, Gastric Cancer, Hepatocellular Carcinoma, and others.

The cost for Cyramza intravenous solution (10 mg/mL) is around $1,513 for a supply of 10 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Cyramza prices

Intravenous Solution

Quantity Per unit Price
10 milliliters $151.34 $1,513.43
50 milliliters $150.58 $7,529.12

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Cyramza Coupons, Copay Cards and Rebates

Cyramza offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional. Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Cyramza Savings Card

Eligible commercially insured patients may pay as little as $25 per monthly dose up to a monthly savings cap; maximum savings of $25,000 per 12-month enrollment period; card expires at the end of each calendar year; for additional information contact the program at 866-472-8663.

Applies to:
Number of uses:
12 times within calendar year
December 31, 2024

Form more information phone: 866-472-8663 or Visit website

Patient Assistance & Copay Programs for Cyramza

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Cyramza (ramucirumab) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: Lilly Cares Foundation Patient Assistance Program

Eligibility requirements:
  1. Contact program for details.
  2. Varies
  3. Not specified
  4. Must be US citizen or a legal permanent resident of the US
  5. Please visit or call (800) 545-6962 for more information. Additional products may be available. Please contact the program for a complete product listing. Lilly donates products to the Lilly Cares Foundation Patient Assistance Program.
Applicable drugs:
  • Cyramza (ramucirumab) Injection; IV

More information please phone: 800-545-6962 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.